<DOC>
	<DOCNO>NCT02736383</DOCNO>
	<brief_summary>To determine TXA utilization effective reduce transfusion rate elderly patient undergo surgery treatment hip fracture .</brief_summary>
	<brief_title>Tranexamic Acid Hip Fracture Surgery</brief_title>
	<detailed_description>Participants randomize one two group : intervention group control group . Participants enrol study 6 week .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Acute , isolate , unilateral femoral neck , intertrochanteric , per trochanteric hip fracture confirm anteroposterior/lateral hip radiograph , compute tomography , magnetic resonance imaging . Age 65 old Low energy mechanism injury Hip fracture fixation perform within 48 hour English speaking Anticipated medical optimization operative fixation No major trauma Unable provide inform consent ( dementia , limited decision make capacity ) Admitted medical service significant comorbidities Unable refusal receive blood product Retained hardware around affect hip Infection around affect hip Transfer patient length stay &gt; 24 hour transfer hospital History deep vein thrombosis ( DVT ) pulmonary embolus ( PE ) within past year On anticoagulation treatment DVT PE , currently within past 12 month Diagnosis deficient natural anticoagulation Known congenital thrombophilia ( Deficiency Protein C , S , Antithrombin ) Known allergy TXA History seizure disorder Cardiac stent ischemic stroke within 1 year Concomitant subarachnoid hemorrhage Active intravascular clot Prisoner Patients undergo percutaneous pin hip fracture Patients renal impairment ( serum creatinine &gt; 1.5 creatinine clearance &lt; 50 ml/min )</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>